Navigation Links
MAP Pharmaceuticals to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
Date:6/4/2008

MOUNTAIN VIEW, Calif., June 4 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Company will present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on Tuesday, June 10, 2008, at 4:00 pm (PT) in Dana Point, California.

A live webcast of the presentation will be available on the Investor Relations section of MAP Pharmaceuticals' website at http://www.mappharma.com. A replay will also be available within 24 hours for seven days following the presentation.

About MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals develops and plans to commercialize new therapies for children and adults who suffer from chronic conditions that it believes are not adequately treated by currently available medicines. The Company applies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates, Unit Dose Budesonide and MAP0004, in late stage development for the potential treatment of pediatric asthma and migraine respectively. MAP Pharmaceuticals' pipeline also includes a drug candidate in early clinical development for the treatment of asthma and chronic obstructive pulmonary disease.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.


'/>"/>
SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
2. Antipodean Pharmaceuticals Announces FDA Acceptance of IND for MitoQ(R)
3. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
4. Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
5. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
6. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
7. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
8. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
9. Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
10. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
11. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...e,Nov.27/PRNewswire/--TeamGarmin-Slipstream,theeli...lsportinganddevelopingthenextgenerationofcyclingch...ransitionswiththeadditionofTransitionsOpticalasane...adingmanufacturerofadaptiveeyewear,offeringthemost...ofspectaclelensessuchasTransitionslensesaswellasTr...
(Date:11/27/2009)...re/-- Allrecipes.com , theworld,s#1foodsite,recei...han2.8millionvisitorsthedaybeforeThanksgiving,prov...olidayoftheyear.TheaverageThanksgivingmealin2009we...fromlastyear,sfeast.AccordingtotheAllrecipessite, ...givingrecipe,acontrastfromlastyear,spopular Homest...
(Date:11/26/2009)...re/--Withcoldandfluseasonuponus,it,smoreimportantt...fectionsandavoidillness. ,, "Weneedtobeproactiv...ingillnessifwe,resick,"saidEileenFinerty,RN,MS,CIC...nfectioncontrolandoccupationalhealthatHospitalforS...ecialSurgeryhasoneofthelowestinfectionratesofanyho...
(Date:11/26/2009)...n an emotional rollercoaster, study finds , ...t the fear factor meets the jubilant sports fan. ,...ally those who root for the winning team -- enjoy ...ted match and victory was in doubt, producing feel...this Thanksgiving weekend as you,re glued to the T...
(Date:11/26/2009)... & Ennis, P.A. is offering free nationwide con...n birth control pills who have suffered a Deep Vei...art Attack or other related cardiac issues or had ...e at 1-800-856-6405 or go to the firm’s webs...nline case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
... Against the backdrop of growing health concerns a...fats on health, consumers are ratcheting up pressu...merging as ideal substitutes for hydrogenated fats... upward trajectory. , , (Logo: http://www.newsco...
...y research team has found that a painful pelvic af...ently in adolescent boys. Chronic prostatitis or c...tal disease associated with persistent and life-al...ve impact that pain, urinary symptoms, and depress...
...sure, Reduces Procedure Time, Lowers , Costs , , ...of Ottawa Heart Institute (UOHI) has installed No...-ray for clinical use, allowing physicians to more... a similar amount and offers other benefits. , "Th...
...ased today titled Assessing State Firefighter Can...r Research , found there is inadequate scientific ...firefighter and an elevated risk of contracting ca...ble to determine that firefighters face risks grea...
... of 105 post-menopausal vegan Buddhist nuns and 10...sical respect, has produced a surprising result. T...led by Professor Tuan Nguyen from Sydney,s Garvan ...r findings are now published online in Osteoporos...
...ore.com , inc. (Nasdaq: DSCM ), a leading online...products, will announce its financial results for ... Wednesday, April 29, 2009 at 5:00 p.m. ET (2:00 p....investor.drugstore.com . , , (Logo: http://ww...
Other Medicine News:Health News:Innovation and Strategic Alliances Come to the Rescue of Participants in Mature Brazilian Market for Food Emulsifiers, Finds Frost & Sullivan 2Health News:Innovation and Strategic Alliances Come to the Rescue of Participants in Mature Brazilian Market for Food Emulsifiers, Finds Frost & Sullivan 3Health News:Innovation and Strategic Alliances Come to the Rescue of Participants in Mature Brazilian Market for Food Emulsifiers, Finds Frost & Sullivan 4Health News:Pelvic pain as prevalent in teens as older males, Queen's researchers discover 2Health News:University of Ottawa Heart Institute is North America's First Clinical Site for Ultra-sophisticated X-Ray 2Health News:Study Fails to Establish Link Between Cancer and Firefighting 2Health News:Vegan Buddhist nuns have same bone density as non-vegetarians 2Health News:drugstore.com, inc. to Announce First Quarter 2009 Results During Conference Call on Wednesday, April 29, 2009 at 5:00 p.m. ET 2
(Date:11/25/2009)...andSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareI...nnovatorandprovideroflessinvasive,miniaturizedcirc...entofadvancedheartfailure,todayannouncedthatitissc...PiperJaffrayHealthCareConferenceat8:00amESTonWedne...ewYorkPalaceHotel,December1-2. ,, Alivewebcasto...
(Date:11/24/2009)....24/PRNewswire-Asia/--ChindexInternational,Inc.,("...anproviderofWestern,healthcareproductsandservicesi...Companywillattendthe21stAnnualPiperJaffray,"Unplug...atthe,NewYorkPalaceHotel. , Managementiscurre...er1,2009,andholdone-on-onemeetingsthroughouttheday...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--Endologix,Inc.(Nasdaq:...orticdisorders,announcedtodaythatithasfiledamotion...ingementlawsuitbroughtagainstitinOctober2009byCook...rtinIndianapolis,Indiana. ,, Endologixhasreques...tentandTrademarkOffice(USPTO)conductsproceedingsto...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2China Biologic Products Hosts its First Forum for Strategy and Development 13057 1China Biologic Products Hosts its First Forum for Strategy and Development 13057 2China Biologic Products Hosts its First Forum for Strategy and Development 13057 3Ready 3F AIM 21 Target Success 21 AIM Expands Global Reach Through Innovative Corporate Portal from Web to Enterprise 2 0 51877 1Ready 3F AIM 21 Target Success 21 AIM Expands Global Reach Through Innovative Corporate Portal from Web to Enterprise 2 0 51877 2Oncolytics Biotech 28R 29 Inc Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC 4734 1Oncolytics Biotech 28R 29 Inc Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC 4734 2
...GEFIELD, Conn., Jan. 17 Boehringer Ingelheim,anno...ndmark RE-LY trial to,evaluate the long-term effic...mbin inhibitor dabigatran etexilate for the preven...ith atrial fibrillation. RE-LY (Randomized,Evaluat...gest stroke,prevention in atrial fibrillation tria...
...LO PARK, Calif., Jan. 16 Cogentus Pharmaceuticals...linical study to confirm,the full antiplatelet act...CGT-2168 is a once-daily capsule that combines clo...bb Co. and Sanofi-Aventis as Plavix(R)) with,a gas...testinal safety of,antiplatelet therapy., (Logo: ...
Other Medicine Technology:Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study 2Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study 3Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study 4Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168 2
BD Micro-Sharp Blades and BD Micro-Unitome Knives
BD Visitec Nucleus Spatulas
...tions which enable procedure-specific modification...figurations to accomadate individual draping. Refr...cedure-specific modifications, Drape adapts to var...ate individual draping. Soft, comfortable material...
BD Visitec Irrigating Cannulas
Medicine Products: